Drug Trial Radar · NCT02145546
Antiarrhythmic Drugs Assessment in Preventing Atrial Fibrillation
Last checked: Nov 19, 2026Latest source record: May 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
600
Planned (sponsor's estimate)
Start
May 2014
Primary completion
May 2017
Study completion May 2017
Sponsor
- Lead sponsor
- Xinhua Hospital, Shanghai Jiao Tong University School of MedicineAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Medtronic (Shanghai) Management Co. Ltd.; Beijing CTSmed Co. Ltd
- First posted
- May 23, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The current evidences indicate that \~30% patients with sick sinus syndrome(SSS) would develop persistent atrial fibrillation (AF) after a long term pacing therapy. However, the accurate influence of antiarrhythmic drugs on the AF is still not well defined. The purpose of the study is to assess the therapeutic effects of various antiarrhythmic drugs (Amiodarone, Sotalol and Propafenone) on the long term management of AF in SSS patients with AF, including the reduced AF burden (duration and episodes) and persistent AF free survival rate. All patients will be followed up for 12 months.
Conditions
- Atrial Fibrillation
Interventions
AmiodaroneDrug
Amiodarone: 200mg three times a day for two weeks, then change to 200mg per day for the rest of the study.
PropafenoneDrug
150mg per 8 hours, 3 times per day
SotalolDrug
80mg twice per day.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average AF burden in minutes per dayTime frame: monthly up to 12 months
- Persistent AF free survival rateTime frame: monthly up to12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicne
Shanghai, Shanghai Municipality, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.